$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock

₹310
INTRODUCTION CCQ 50MG TABLET is a combination of Clomifene and Ubidecarenone which belongs to the group of medicines called Ovulation stimulants and Antioxidants respectively. It is used in the treatment of infertility in women (women are not ovulating properly). The main...
CCQ 50MG TABLET is a combination of Clomifene and Ubidecarenone which belongs to the group of medicines called Ovulation stimulants and Antioxidants respectively. It is used in the treatment of infertility in women (women are not ovulating properly).
The main symptom of infertility is the inability to get pregnant, a menstrual cycle that's too long (35 days or more), too short (less than 21 days), irregular or absent can mean you're not ovulating.
CCQ 50MG TABLET is not recommended for use if you have or had liver disease, unusual menstrual bleeding with unknown cause, have a type of cancer that is worsened by hormones, a cyst on your ovary.
Before taking CCQ 50MG TABLET inform your doctor if you are having early menopause, are infertile, stopped having periods because of underweight, had fits or seizures in the past, have fibroids in the womb, have polycystic ovaries, ovaries are swollen, have hypertriglyceridemia (an excess of fats in the blood).
CCQ 50MG TABLET is not recommended for use in pregnant women and inform your doctor before taking this medicine if you are breast-feeding a baby. It is not recommended for use in children and adolescents below 18 years of age.
The most common side effects of taking CCQ 50MG TABLET are nausea, vomiting, blurred vision and pelvic pain. Consult your doctor if any of the side effects worsen.
CCQ 50MG TABLET contains clomifene which acts by increasing the gonadotrophin hormones secreted by pituitary glands which in turn stimulates the maturation and endocrine activity of the ovarian follicle (stimulates the release of eggs from the ovary). Ubidecarenone protects the body from damage by chemicals that cause infertility.
Take CCQ 50MG TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the right dose and duration depending upon your age, body weight and disease condition.
Stop taking CCQ 50MG TABLET and contact your doctor immediately if you experience any of the following side effects:
Nausea and vomiting:
Stick to simple meals. Avoid eating oil rich, fried or spicy food. Consult your doctor if the symptom does not improve.
CCQ 50MG TABLET is not recommended for use in pregnant women or women planning to have a baby. Consult your doctor before taking CCQ 50MG TABLET.
Inform your doctor if you are breastfeeding before taking CCQ 50MG TABLET as it can lower the amount of milk produced. Consult your doctor before taking it.
Do not drive or use machines while taking CCQ 50MG TABLET as it may cause blurred vision.
CCQ 50MG TABLET is not recommended for use in patients with liver disease or history of liver disease. Consult your doctor before taking it.
Do not take CCQ 50MG TABLET if you are allergic to Clomifene or Ubidecarenone or any other ingredients of this medicine.
CCQ 50MG TABLET is not recommended for use if you:
Before taking CCQ 50MG TABLET, inform your doctor if you:
Use in pediatrics:
CCQ 50MG TABLETis not recommended for use in children and adolescents below 18 years of age. Consult your child’s doctor for advice.
A. Drug - Drug interactions:
Before taking CCQ 50MG TABLET, inform your doctor if you are taking any medicines including prescription, non-prescription and herbal supplements
Overdosage:
If you or anyone else accidentally take too much of CCQ 50MG TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are over-stimulation of the ovary (pain in the pelvis, stomach or calves, feeling bloated, passing less urine, difficulty in breathing or an increase in weight).
| Drug | : | Clomifene citrate, Ubidecarenone |
| Pharmacological Category | : | Ovulation stimulant, Antioxidant |
| Therapeutic Indication | : | Infertility in women |
| Dosage Forms | : | Tablet, Capsule |
What is CCQ 50MG TABLET used for?
CCQ 50MG TABLET is used in the treatment of infertility in women (women are not ovulating properly). The main symptom of infertility is the inability to get pregnant, a menstrual cycle that's too long, too short, irregular or absent can mean you're not ovulating.
Can CCQ 50MG TABLET be used in pregnant women?
CCQ 50MG TABLETis not recommended for use in pregnant women or women who are planning to have a baby. Consult your doctor for advice before taking this medicine if you are pregnant or planning to get pregnant.
What if I forget to take a dose of CCQ 50MG TABLET?
You should take CCQ 50MG TABLET immediately when you remember. If it is time for your next dose skip the dose and follow your regular dose schedule. Do not double the dose to match up your missed dose.
Can I drive while taking CCQ 50MG TABLET?
Do not drive or use machines while taking CCQ 50MG TABLET as you may have problems with your eyesight causing blurred vision affecting your ability to drive or use machines. Consult your doctor before taking it.
How does CCQ 50MG TABLET work?
CCQ 50MG TABLET contains clomifene which acts by increasing the gonadotrophin hormones secreted by pituitary glands which in turn stimulates the maturation and endocrine activity of the ovarian follicle (stimulates the release of eggs from the ovary). Ubidecarenone protects the body from damage by chemicals that cause infertility.
1. KD Tripathi. Estrogens, Progestins and Contraceptives. Essentials of medical pharmacology. Eighth Edition. 2019. Page –337
2. Abdelaziz El Refaeey, Amal Selem, Ahmed Badawy. Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. [Revised on March 2014] [Accessed on 30th July 2022] https://www.rbmojournal.com/article/S1472-6483(14)00178-3/fulltext#relatedArticles
3. E Y Kang, J W Choi, H S Gwak, I K Chun. Comparison of bioavailability of two ubidecarenone products in healthy Korean volunteers. [Accessed on 30th July 2022] https://pubmed.ncbi.nlm.nih.gov/19281730/
4. Zentiva k.s. Electronic Medicines Compendium (EMC). [Revised in June 2021] [Accessed on 30th July 2022] https://www.medicines.org.uk/emc/files/pil.961.pdf
5. Magis Pharma S.r.l. Ubidecarenone. [Revised in March 2017] [Accessed on 30th July 2022] https://www.magispharma.it/media/ubicor/download/en/15785752395e172587c8bd2.pdf
Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 07 Jan 2023 | 03:41 PM(IST)